Evidence map›Paper›PMID 41942855›Full record

ArticleBMC genomics2026

From SNPs to pathways: a genome-wide benchmark of annotation discrepancies and their impact on protein- and pathway-level inference.

Bryan Queme, Anushya Muruganujan, Dustin Ebert, Tremayne Mushayahama, W James Gauderman, Huaiyu Mi

Abstract read
In one paragraph

Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Bryan QuemeDivision of Biostatistics and Health Data Science, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
Anushya MuruganujanDivision of Biostatistics and Health Data Science, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
Dustin EbertDivision of Biostatistics and Health Data Science, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
Tremayne MushayahamaDivision of Biostatistics and Health Data Science, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
W James GaudermanDivision of Biostatistics and Health Data Science, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
Huaiyu MiDivision of Biostatistics and Health Data Science, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, 90089, USA. huaiyumi@usc.edu.

Funding

Statistical Methods for Integrative Genomics in CancerP01CA196569 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI David V Conti · 2016 to 2026
$25.5M
NCI NIH HHS P01 CA196569NIH HHS P01-CA196569
6 · The paper itself

Abstract

backgroundAccurate single-nucleotide polymorphism (SNP) annotation is central to genomic research yet widely used tools and gene models often yield divergent results. Prior studies have shown such discrepancies in small datasets, but the extent of genome-wide variation and its impact on downstream pathway analysis remain unclear.

resultsWe conducted a comprehensive comparison of three commonly used SNP annotation tools, ANNOVAR, SnpEff, and VEP, using both Ensembl and RefSeq gene models to evaluate more than 40 million SNPs from the Haplotype Reference Consortium. At the protein level, annotation output differed significantly across tools and gene models (p-adj < 0.001), with discrepancies present in both genic and intergenic regions. RefSeq produced broader annotation coverage, particularly for intergenic SNPs, while Ensembl showed greater internal consistency. SnpEff provided the most complete coverage overall, whereas no single tool or model configuration achieved full annotation recovery of the union reference. Integration across tools and models maximized coverage and reduced annotation loss. In a case study of 204 colorectal cancer–associated SNPs from the FIGI GWAS, pathway enrichment results varied depending on annotation strategy. The fully integrated approach identified all four significant pathways, whereas several single-tool or single-model strategies missed one or more.

conclusionSNP annotation outcomes are influenced by both the tool and gene model used, and relying on a single approach may result in incomplete coverage. A multi-tool, multi-model strategy provides the most comprehensive annotation and preserves enriched pathways, supporting more robust and reproducible genomic interpretation.

Indexed as

Molecular Sequence AnnotationPolymorphism, Single NucleotideColorectal NeoplasmsGenome-Wide Association StudyGenomicsHumansANNOVAREnsemblGenome-wide analysisPathway enrichmentRefSeqSNP annotationSnpEffVariant annotationVariant Effect Predictor (VEP)

Identifiers

PMID41942855
PMCPMC13188793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.